These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Diminished Susceptibility to Cefoperazone/Sulbactam and Piperacillin/Tazobactam in Yang F; Zhao Q; Wang L; Wu J; Jiang L; Sheng L; Zhang L; Xue Z; Yi M Pol J Microbiol; 2022 Jun; 71(2):251-256. PubMed ID: 35716168 [TBL] [Abstract][Full Text] [Related]
23. Analysis of virulence phenotypes and antibiotic resistance in clinical strains of Acinetobacter baumannii isolated in Nashville, Tennessee. Boone RL; Whitehead B; Avery TM; Lu J; Francis JD; Guevara MA; Moore RE; Chambers SA; Doster RS; Manning SD; Townsend SD; Dent L; Marshall D; Gaddy JA; Damo SM BMC Microbiol; 2021 Jan; 21(1):21. PubMed ID: 33422000 [TBL] [Abstract][Full Text] [Related]
24. Forehead abscess caused by Klebsiella oxytoca with undiagnosed type 2 diabetes. Sohn WI; Seo BF; Jung SN J Craniofac Surg; 2012 May; 23(3):e247-9. PubMed ID: 22627446 [TBL] [Abstract][Full Text] [Related]
25. In vitro comparative activity of the new beta-lactamase inhibitor taniborbactam with cefepime or meropenem against Klebsiella pneumoniae and cefepime against Pseudomonas aeruginosa metallo-beta-lactamase-producing clinical isolates. Meletiadis J; Paranos P; Georgiou PC; Vourli S; Antonopoulou S; Michelaki A; Vagiakou E; Pournaras S Int J Antimicrob Agents; 2021 Nov; 58(5):106440. PubMed ID: 34551356 [TBL] [Abstract][Full Text] [Related]
26. Characterization of OXA-48-producing Klebsiella oxytoca isolates from a hospital outbreak in Tunisia. Guzmán-Puche J; Jenayeh R; Pérez-Vázquez M; Manuel-Causse ; Asma F; Jalel B; Oteo-Iglesias J; Martínez-Martínez L J Glob Antimicrob Resist; 2021 Mar; 24():306-310. PubMed ID: 33545421 [TBL] [Abstract][Full Text] [Related]
27. The rates of quinolone, trimethoprim/sulfamethoxazole and aminoglycoside resistance among Enterobacteriaceae isolated from urinary tract infections in Azerbaijan, Iran. Yekani M; Baghi HB; Sefidan FY; Azargun R; Memar MY; Ghotaslou R GMS Hyg Infect Control; 2018; 13():Doc07. PubMed ID: 30202721 [No Abstract] [Full Text] [Related]
28. Clinical carbapenem-resistant Shahid M; Ahmad N; Saeed NK; Shadab M; Joji RM; Al-Mahmeed A; Bindayna KM; Tabbara KS; Dar FK Front Cell Infect Microbiol; 2022; 12():1033305. PubMed ID: 36304935 [TBL] [Abstract][Full Text] [Related]
29. Ciprofloxacin-Resistant Panholzer J; Neuboeck M; Shao G; Heldt S; Winkler M; Greiner P; Fritsch N; Lamprecht B; Salzer H Case Rep Pulmonol; 2022; 2022():1008330. PubMed ID: 35223121 [TBL] [Abstract][Full Text] [Related]
30. [Analysis of the pathogenic characteristics of 162 severely burned patients with bloodstream infection]. Gong YL; Yang ZC; Yin SP; Liu MX; Zhang C; Luo XQ; Peng YZ Zhonghua Shao Shang Za Zhi; 2016 Sep; 32(9):529-35. PubMed ID: 27647068 [TBL] [Abstract][Full Text] [Related]
31. Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents. Bader MS; Loeb M; Leto D; Brooks AA Postgrad Med; 2020 Apr; 132(3):234-250. PubMed ID: 31608743 [TBL] [Abstract][Full Text] [Related]
32. Oral versus intravenous antibiotics for patients with Klebsiella pneumoniae liver abscess: study protocol for a randomized controlled trial. Molton J; Phillips R; Gandhi M; Yoong J; Lye D; Tan TT; Fisher D; Archuleta S Trials; 2013 Oct; 14():364. PubMed ID: 24176222 [TBL] [Abstract][Full Text] [Related]
33. Clinical and microbiologic analysis of a hospital's extended-spectrum beta-lactamase-producing isolates over a 2-year period. Burgess DS; Hall RG; Lewis JS; Jorgensen JH; Patterson JE Pharmacotherapy; 2003 Oct; 23(10):1232-7. PubMed ID: 14594340 [TBL] [Abstract][Full Text] [Related]
34. Recurrent Primary Suprahepatic Abscess Due to Providencia Stuartii: A Rare Phenomenon. Lin K; Lin AN; Linn S; Reddy M; Bakshi A Cureus; 2017 Sep; 9(9):e1691. PubMed ID: 29158999 [TBL] [Abstract][Full Text] [Related]
36. The treatment of nosocomial meningitis and brain abscess by carbapenem-resistant Chen Y; Liu L Br J Neurosurg; 2023 Aug; 37(4):634-636. PubMed ID: 31342790 [TBL] [Abstract][Full Text] [Related]
37. In vitro activity of ceftaroline, ceftazidime-avibactam, and comparators against Gram-positive and -negative organisms in China: the 2018 results from the ATLAS program. Jia P; Zhu Y; Zhang H; Cheng B; Guo P; Xu Y; Yang Q BMC Microbiol; 2022 Oct; 22(1):234. PubMed ID: 36182895 [TBL] [Abstract][Full Text] [Related]
39. A mimicry of melioidosis by Klebsiella ozaenae infection. Ng TH; How SH; Kuan YC; Adzura ; Aziz AA; Fauzi AR Malays J Pathol; 2009 Dec; 31(2):147-50. PubMed ID: 20514860 [TBL] [Abstract][Full Text] [Related]
40. [Antimicrobial resistance monitoring of gram-negative bacilli isolated from 15 teaching hospitals in 2014 in China]. Wang Q; Wang H; Yu Y; Xu X; Sun Z; Lu J; Yang B; Zhang L; Hu Z; Feng X; Xu Y; Ni Y; Mei Y; Liao K; Ji P; Chu Y Zhonghua Nei Ke Za Zhi; 2015 Oct; 54(10):837-45. PubMed ID: 26675021 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]